SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

Bruker Launches Second-Generation FluoroType SARS-CoV-2 plus PCR Test for Detection of SARS-CoV-2 Viral Infections in Europe

Detects two independent SARS-CoV-2 viral RNA targets from respiratory samples for increased confidence Differentiates SARS-CoV-2 from four other endemic human coronaviruses for specificity Validated with

Benzinga · -
  • Detects two independent SARS-CoV-2 viral RNA targets from respiratory samples for increased confidence
  • Differentiates SARS-CoV-2 from four other endemic human coronaviruses for specificity
  • Validated with Bruker-Hain GenoXtract® NA and GenoXtract® 96 X3 nucleic acid extraction system and kits
  • Validated with novel Bruker-Hain FluoroCycler® XT real-time PCR thermocycler